Mechanism of the anti-tumour effect of 2,3,5-trimethyl-6-(3-pyridylmethyl) I ,4-benzoquinone (CV-6504)
1997
Anti-tumour effect of CV-6504
Sample size: 9
publication
Evidence: moderate
Author Information
Author(s): HJ Hussey, MJ Tisdale
Primary Institution: Pharmaceutical Sciences Institute, Aston University
Hypothesis
CV-6504 inhibits the metabolism of arachidonic acid through lipoxygenase pathways to suppress tumor growth.
Conclusion
CV-6504 effectively reduces tumor growth and cachexia in mice by inhibiting fatty acid metabolism.
Supporting Evidence
- CV-6504 reduced tumor volume and cachexia in mice.
- CV-6504 inhibited the conversion of arachidonic acid to lipoxygenase metabolites in sensitive cell lines.
- Different cell lines showed varying sensitivity to CV-6504 based on their fatty acid requirements.
Takeaway
CV-6504 is a medicine that helps stop tumors from growing by blocking certain fats that the tumors need.
Methodology
The study involved administering CV-6504 to mice with MAC16 tumors and analyzing tumor growth and fatty acid metabolism.
Limitations
The study was conducted on a limited number of cell lines and animal models.
Participant Demographics
Female NMRI mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website